Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -22.1% | 4.1% | -2.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 73.7% | 77.5% | 78.8% | 79.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -65.3% | -187.5% | -70.5% | -88.5% |
| Net Income | -$0 | -$1 | -$0 | -$0 |
| % Margin | -72% | -211.5% | -89.5% | -150% |
| EPS Diluted | -0.31 | -1.16 | -0.47 | -0.81 |
| % Growth | 73.3% | -146.8% | 42% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |